Prescription drug wholesaler pleads guilty to smuggling counterfeit cancer drugs
The FDA recently reported that the owner of a Turkish drug wholesaler has pleaded guilty to charges of smuggling misbranded and adulterated cancer treatment drugs into the United States. Sabahaddin Akman, owner of the Turkish firm Ozay Pharmaceuticals, pleaded guilty in the U.S. District Court for the Eastern District of Missouri, to smuggling counterfeit cancer drugs including multiple shipments of Altuzan, the Turkish version of bevacizumab (Avastin, Genentech).
The drugs did not meet FDA standards and had not been approved for distribution in the United States. The FDA’s Office of Criminal Investigations organized an international investigation that led to Akman’s arrest in Puerto Rico in January 2014. The investigation identified Akman and his company as a source of Altuzan.
Related Posts
Alibaba’s anti-counterfeit codes
Consumer goods giant Unilever has joined forces with Alibaba in a programme that...
Smuggled Cabbage for Kimchi Season
In many regions of North Korea, a lack of fertilizer and the spring drought have...
Turkey 2nd in world for counterfeit product volume, report
The total volume of counterfeit or pirated products in the Turkish market is...
Counterfeit goods sales busted at swap shop
An undercover investigation in the sale of counterfeit goods with an actual...